NanoRepro AG (NN6):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:NanoRepro AG (NN6) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8078
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
NanoRepro AG (NanoRepro) is a manufacturer of fast-diagnostics and nutritional food supplements for home and clinical use. The company offers wide range of rapid diagnostic tests products in the areas of family planning, disease detection (preventive healthcare), food intolerances, allergies and infectious diseases. Its products portfolio includes ovuquick, graviquick, glutencheck, cholesterincheck, fertiquick, vagiquick, menoquick, graviquick fruhtest, fobcheck, heli-c-check, alkoholtest, milkcheck, allergocheck, and eiercheck. The company works in partnership with companies and institutions including University of Marburg, Research Center for Medical Engineering and Biotechnology, Bad Langensalza, Germany. Dedicare AB, Hartmann USA, Inc., Farmaceutica Remedia SA, and others. The Company markets its products through a network of distributors worldwide. NanoRepro is headquartered in Marburg, Germany.

NanoRepro AG (NN6) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
NanoRepro AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
NanoRepro AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
NanoRepro AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
NanoRepro AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
NanoRepro AG, Medical Devices Deals, 2012 to YTD 2018 9
NanoRepro AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
NanoRepro AG, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
NanoRepro Acquires Alphabiol Brand from Alphablom 11
Equity Offering 12
Nanorepro Raises USD0.6 Million in Rights Offering of Shares 12
NanoRepro Raises USD1 Million in Rights Offering of Shares 13
NanoRepro to Raise Funds through Public Offering of Shares 14
NanoRepro Raises USD1.7 Million in Rights Offering of Shares 15
NanoRepro Raises USD1.1 Million in Rights Offering of Shares 16
NanoRepro AG – Key Competitors 17
NanoRepro AG – Key Employees 18
NanoRepro AG – Locations And Subsidiaries 19
Head Office 19
Recent Developments 20
Financial Announcements 20
Apr 25, 2018: NanoRepro Increases Sales and Achieves Positive Operating Result (EBITDA) 20
Dec 05, 2017: NanoRepro With Higher Sales and Better Results 21
Aug 03, 2017: NanoRepro Increases Growth in the Second Quarter 22
Apr 25, 2017: NanoRepro: Sales Grow in the First Quarter 23
Apr 21, 2017: NanoRepro: Company Expects Revenue to Increase by at Least 30% in 2017 24
Jan 25, 2017: NanoRepro Announces Preliminary Figures for the 2016 Financial Year 25
Other Significant Developments 26
Apr 10, 2018: NanoRepro Reaches Its Annual Targets and Wants to Grow Strongly in 2018 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
NanoRepro AG, Pharmaceuticals & Healthcare, Key Facts, 2017 2
NanoRepro AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
NanoRepro AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
NanoRepro AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
NanoRepro AG, Deals By Therapy Area, 2012 to YTD 2018 8
NanoRepro AG, Medical Devices Deals, 2012 to YTD 2018 9
NanoRepro AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
NanoRepro Acquires Alphabiol Brand from Alphablom 11
Nanorepro Raises USD0.6 Million in Rights Offering of Shares 12
NanoRepro Raises USD1 Million in Rights Offering of Shares 13
NanoRepro to Raise Funds through Public Offering of Shares 14
NanoRepro Raises USD1.7 Million in Rights Offering of Shares 15
NanoRepro Raises USD1.1 Million in Rights Offering of Shares 16
NanoRepro AG, Key Competitors 17
NanoRepro AG, Key Employees 18

List of Figures
NanoRepro AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
NanoRepro AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
NanoRepro AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
NanoRepro AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
NanoRepro AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
NanoRepro AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
NanoRepro AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
NanoRepro AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
NanoRepro AG, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[NanoRepro AG (NN6):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • YTL Power International Bhd (YTLPOWR)
    YTL Power International Bhd (YTLPOWR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Valener Inc:企業の戦略的SWOT分析
    Valener Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Biovista Inc-製薬・医療分野:企業M&A・提携分析
    Summary Biovista Inc (Biovista) is a drug development company that provides COSS platform technology support in uncovering non-obvious correlations between drugs. The company’s products are used for the treatment of neurodegenerative diseases, epilepsy, oncology and orphan diseases. It offers servic …
  • Cogeco Peer 1 (UK) Ltd:企業の戦略・SWOT・財務情報
    Cogeco Peer 1 (UK) Ltd - Strategy, SWOT and Corporate Finance Report Summary Cogeco Peer 1 (UK) Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Keystone Foods LLC:企業の戦略・SWOT・財務情報
    Keystone Foods LLC - Strategy, SWOT and Corporate Finance Report Summary Keystone Foods LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Vectrus Inc (VEC):企業の財務・戦略的SWOT分析
    Vectrus Inc (VEC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Sealed Air Corporation:企業の戦略・SWOT・財務情報
    Sealed Air Corporation - Strategy, SWOT and Corporate Finance Report Summary Sealed Air Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Topy Industries Ltd:企業の戦略・SWOT・財務情報
    Topy Industries Ltd - Strategy, SWOT and Corporate Finance Report Summary Topy Industries Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Venture Corporation Limited:企業の戦略・SWOT・財務情報
    Venture Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary Venture Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • United Community Banks Inc:企業のM&A・事業提携・投資動向
    United Community Banks Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's United Community Banks Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • Evoqua Water Technologies Corp (AQUA):企業の財務・戦略的SWOT分析
    Evoqua Water Technologies Corp (AQUA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Axpo Holding AG-エネルギー分野:企業M&A・提携分析
    Summary Axpo Holding AG (Axpo) is an electricity utility that produces, trades and sells electricity. It is wholly owned by the cantons of Northeastern Switzerland. The company covers the entire value chain from power generation and marketing of a wide range of products to power distribution. It gen …
  • Fresenius Kabi USA LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Fresenius Kabi USA LLC (Fresenius Kabi), a subsidiary of Fresenius Kabi AG, is a pharmaceutical and medical device company which provides lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. It provides products and services to critically and chronically il …
  • Inter Parfums Inc (IPAR):企業の財務・戦略的SWOT分析
    Summary Inter Parfums Inc (Inter Parfums) is a consumer goods company that manufactures, develops, and markets fragrance and beauty care products. The company’s products include cosmetics, fragrances, personal care products, and fragrance related products. Its personal care products comprise cosmeti …
  • ILF Consulting Engineers:企業の戦略・SWOT・財務情報
    ILF Consulting Engineers - Strategy, SWOT and Corporate Finance Report Summary ILF Consulting Engineers - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Radiation Monitoring Devices Inc:企業の製品パイプライン分析2018
    Summary Radiation Monitoring Devices Inc (RMD), a subsidiary of Dynasil Corporation of America, is a research and development company that provides solutions for security, medical and industrial applications. The company’s products include scintillators, APDs, cesium iodide, solid state photomultipl …
  • Genentech Inc:医療機器:M&Aディール及び事業提携情報
    Summary Genentech Inc (Genentech), a subsidiary of F. Hoffmann-La Roche Ltd, is a biotechnology company that discovers, develops, manufactures and commercializes medicines to address serious medical needs. It offers drugs in various therapeutic areas including bio-oncology, immunology, ophthalmology …
  • ZoomMed Inc (ZMD):医療機器:M&Aディール及び事業提携情報
    Summary ZoomMed Inc (ZoomMed) is a technical service provider that offers web solutions for medical sectors. The company’s product includes ZoomMed Network, ZRx Prescriber, PraxisLab, and EvPsych. It builds and operates a clinical information exchange platform between physicians and specialists, pat …
  • Enviva Partners LP (EVA):企業の財務・戦略的SWOT分析
    Enviva Partners LP (EVA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Mundipharma International Ltd:企業の戦略的SWOT分析
    Mundipharma International Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆